Trimtech Raises £25m in Seed Round Backed by Cambridge Innovation Capital

Deal News | Mar 06, 2025 | UK Tech Funding

Trimtech Raises £25m in Seed Round Backed by Cambridge Innovation Capital

Trimtech Therapeutics, a biotech spinout from the University of Cambridge, has secured £25m in a seed funding round. The round was co-led by Cambridge Innovation Capital (CIC) and the Dementia Discovery Fund from SV Health Investors. This investment will aid Trimtech in the development of treatments for neurodegenerative diseases, focusing on targeted protein degradation. CIC, having launched its £100m fund the previous month, is supporting domestic deep tech companies like Trimtech to reduce reliance on overseas funding. Alongside CIC and DDF, major players such as Pfizer Ventures, M Ventures, Eli Lilly and Company, MP Healthcare Venture Management, Cambridge Enterprise Ventures, and Start Codon participated in the round. The funds will further Trimtech’s mission to create significant medical advancements for dementia and other central nervous system disorders.

Sectors

  • Biotechnology
  • Venture Capital
  • Pharmaceuticals

Geography

  • United Kingdom – Trimtech Therapeutics is a spinout from the University of Cambridge, and the funding is led by Cambridge Innovation Capital, based in the UK.
  • United States – Mentions of companies like Pfizer, Eli Lilly, and the trend of moving operations to the US reflect its relevance.

Industry

  • Biotechnology – The article focuses on Trimtech Therapeutics, a university spinout working on biotech innovations for neurodegenerative diseases.
  • Venture Capital – The funding round was co-led by Cambridge Innovation Capital, a venture capital firm, highlighting its investment in deep tech startups.
  • Pharmaceuticals – Participants such as Pfizer Ventures and Eli Lilly indicate the pharmaceutical industry's involvement in funding biotech innovations.

Financials

  • £25m – The total amount raised in Trimtech's seed funding round.
  • £100m – The fund launched by Cambridge Innovation Capital for deep tech investments.

Participants

NameRoleTypeDescription
Trimtech TherapeuticsTarget CompanyCompanyA university spinout biotech company focused on neurodegenerative diseases.
Cambridge Innovation CapitalCo-lead investorCompanyA venture capital firm investing in deep tech companies, co-leading this funding round.
SV Health Investors Dementia Discovery FundCo-lead investorCompanyCo-leader in the funding round, its fund focuses on dementia-related innovations.
Nicola ThompsonCEOPersonCEO of Trimtech Therapeutics.
Michael AnsteyPartnerPersonPartner at Cambridge Innovation Capital, involved in the funding.
Laurence BarkerPartnerPersonPartner at SV Health Investors Dementia Discovery Fund, involved in the funding.
Pfizer VenturesInvestorCompanyParticipated in the seed funding round.
M VenturesInvestorCompanyParticipated in the seed funding round.
Eli Lilly and CompanyInvestorCompanyParticipated in the seed funding round.
MP Healthcare Venture ManagementInvestorCompanyParticipated in the seed funding round.
Cambridge Enterprise VenturesInvestorCompanyParticipated in the seed funding round.
Start CodonInvestorCompanyParticipated in the seed funding round.